Free Trial
LON:CYBG

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis

GBX 15.12 -0.03 (-0.20%)
As of 10/8/2025 03:47 AM Eastern

About VanEck Bionic Engineering UCITS ETF A Acc Stock (LON:CYBG)

Advanced

Key Stats

Today's Range
15.12
15.12
50-Day Range
14.75
15.77
52-Week Range
13.68
17.89
Volume
9,822 shs
Average Volume
272 shs
Market Capitalization
£216.95 million
P/E Ratio
N/A
Dividend Yield
0.20%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYBG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYBG Stock News Headlines

Nvidia’s slow death march
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
VanEck Bionic Engineering UCITS ETF (CYBO.L)
Vaneck Sustainable World Ew Ucits Etf Share Chat
VanEck Global Mining UCITS A (GIGB)
GDX VanEck Gold Miners ETF
See More Headlines

CYBG Stock Analysis - Frequently Asked Questions

VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 16.50 at the start of the year. Since then, CYBG shares have decreased by 8.3% and is now trading at GBX 15.12.

Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include National Australia Bank (NAB), Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken Ab Publ (SVNLY) and Western Union (WU).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Finance
Industry
Banks - Regional - Europe
Sub-Industry
N/A
Current Symbol
LON:CYBG
CIK
N/A
Fax
N/A
Employees
5,762
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
0.01
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
£1.24 billion
Price / Sales
0.18
Cash Flow
GBX 113.12 per share
Price / Cash Flow
0.13
Book Value
GBX 355.10 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
1,434,489,984
Free Float
N/A
Market Cap
£216.95 million
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (LON:CYBG) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners